Navigation Links
VNUS Medical Technologies to Report First-Quarter 2008 Results and Webcast Teleconference on April 21
Date:4/7/2008

SAN JOSE, Calif., April 7, 2008, /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of peripheral vascular disease, announced today that it plans to report its financial results for the first quarter ended March 31, 2008, after the close of market on April 21.

VNUS plans to host its regular quarterly teleconference at 2:00 p.m. PT / 5:00 p.m. ET on April 21. This call will be webcast live for all investors and archived on the company's website at http://www.vnus.com/.

How to Access the Teleconference Webcast

VNUS Medical Technologies First-Quarter 2008 Teleconference

Monday, April 21

2:00 p.m. PT / 5:00 p.m. ET

Go to the home page of the VNUS investor relations website at http://ir.vnus.com/ and click on the webcast icon. From this site, you can listen to the teleconference, assuming that your computer system is configured properly. In addition to the webcast replay, a phone replay will be available for seven days after the live call at (719) 457-0820, code number 4678111.

About VNUS Medical Technologies, Inc.

VNUS is a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that is often the underlying cause of painful varicose veins. VNUS sells the Closure(R) system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to close diseased veins through the application of temperature-controlled RF energy. Approximately 300,000 patients have been treated
'/>"/>

SOURCE VNUS Medical Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. MSU engineering team designs innovative medical device
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
9. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...chnique to combat cancer, study says, , ...esearchers have discovered that some cancer cells ...s might lead to new treatments that starve and kil...l cells in the body need to produce energy. They d...requires oxygen. Compared with normal cells, tumor...
(Date:11/21/2008)...rsingCenter.com, the premier site,for online nurs..., has been,updated to improve the interactive exp... by Lippincott Williams & Wilkins (LWW), Nursi...continuing education activities and free,access t...g journals.,Lippincott Williams & Wilkins is ...
(Date:11/21/2008)...neral membership of the Medical,Advertising Hall ...heir Annual,Awards Dinner to be held February 10,... Achievement Award will also be given. , Th... of Fame are: , Ronald Pantello, who began his ...dler & Hennessey. In 1980 he left Sudler &...
(Date:11/21/2008)... genetic damage that can lead to disease , ...ar medications for treating attention-deficit hype...age linked to an increased risk for developing can...earchers at Duke University Medical Center and the...s one that reported biomarkers associated with an ...
Breaking Medicine News(10 mins):Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3Health News:ADHD Medications Don't Pose Cancer Risk 2
...orld statistics regarding the use of tobacco among...e in five 13-15 year olds consume tobacco and its ...e run up to the World Health Organization's World ...s theme will revolve around the topic, ''tobacco: ...
...h concerns among both the pregnant woman and her c...ant working// mothers who undergo a lot of stress ... these children were five ounces lighter than the ...ar to those seen in case pregnant smokers. These p...
...u was developed by Peter Palese, chair, department...n New York City//. He said that it is an alternati...ine for the poultry and it offers protection again...of American researchers inserted the bird flu gene...
... that up to 21% of chronic pain and depression by ... listening, controls pain and makes people feel mo... About 60 people, with an average age of 50, who w...clinics were participated in the controlled clinic...
Other Medicine News:
(Date:11/19/2008)...e/ -- Biotech scientists increasingly are applying...etter understand the effects of novel drug candida...c Engineering & Biotechnology News ( GEN ). T...w compound,s mechanism of action and eventually de...ing to the November 15 issue of GEN . ( http://ww...
(Date:11/18/2008)...n more, make a donation or send a Christmas Seals ...USNewswire/ -- Millions will receive Christmas Sea...n Lung Association. These decorative holiday stamp...ng back to 1907 when the Lung Association led effo...ericans alive today have no vivid memories of how ...
(Date:11/18/2008)...gnosed, elderly AML patients , , PRINCETON,...cals today announced that the first patient has be...of CPX-351 (Cytarabine:Daunorubicin) Liposome Inje...id leukemia (AML). , , The first patient wa...al College of Cornell University and New York Pre...
(Date:11/12/2008)...wswire/ -- A new study being,published in this Fri...question, what causes Parkinson,s disease?, One o...rch into,Parkinson,s disease is what causes the se...ce. Answering this question has been especially di...es of brain cells that produce,dopamine and they a...
Breaking Medicine Technology:GEN Reports on the Trend Toward Predictive Toxicogenomics 2American Lung Association Celebrates 101st Annual Christmas Seals Campaign 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3A Window Into Parkinson's Disease 2LaVoie Group Adds Cancer Therapeutics Company Neotropix 28R 29 to Its Life Science Agency Roster 26846 1LaVoie Group Adds Cancer Therapeutics Company Neotropix 28R 29 to Its Life Science Agency Roster 26846 2Covance Decides to Pursue Its Original Preclinical Strategy in China 7954 1Covance Decides to Pursue Its Original Preclinical Strategy in China 7954 2Combined Insurance Encourages Women to Assess Insurance Plans and Protection During Breast Cancer Awareness Month 26843 1Combined Insurance Encourages Women to Assess Insurance Plans and Protection During Breast Cancer Awareness Month 26843 2Combined Insurance Encourages Women to Assess Insurance Plans and Protection During Breast Cancer Awareness Month 26843 3Combined Insurance Encourages Women to Assess Insurance Plans and Protection During Breast Cancer Awareness Month 26843 4Austin Dentistry Clinic Now Offers Certified Full Service Sedation Dentistry All Gain No Pain 26841 1Austin Dentistry Clinic Now Offers Certified Full Service Sedation Dentistry All Gain No Pain 26841 2
...ot Study Demonstrates 50% Survival in Valortim-Tre..., March 29, 2007,/PRNewswire-FirstCall/ -- Medarex...d PharmAthene, Inc., a privately held,biotechnolog...se,countermeasures, today announced that Valortim(...didate being developed for the,prevention and trea...
...trations Reached in Key Lung Compartments, REINACH...e-FirstCall/ -- Arpida Ltd. today announced promis... These radiolabelled,Human Microdose studies inclu...groundbreaking study is the first ever using Micro...s in lung compartments.,The results showed that AR...
Other Medicine Technology:Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 2Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 3Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 4Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 5Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 6Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 7Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 8Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 2Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 3Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 4Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 5
Low-profile, hand-held instrument.
Low-profile, hand-held instrument.
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries.
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries.
Medicine Products: